000			02029 a2200529 4500
005			20250516140201.0
264		0	_c20131211
008			201312s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdt065 _2doi
040			_aNLM _beng _cNLM
100	1		_aHarvey, V J
245	0	0	_aA randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cJul 2013
300			_a1828-1834 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCapecitabine
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDeoxycytidine _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aLymphatic Metastasis
650	0	4	_aMiddle Aged
650	0	4	_aNeutropenia _xchemically induced
650	0	4	_aTreatment Outcome
700	1		_aSharples, K J
700	1		_aIsaacs, R J
700	1		_aJameson, M B
700	1		_aJeffery, G M
700	1		_aMcLaren, B R
700	1		_aPollard, S
700	1		_aRiley, G A
700	1		_aSimpson, A B
700	1		_aHinder, V A
700	1		_aScott, J N
700	1		_aDzhelali, M V
700	1		_aFindlay, M P
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 24 _gno. 7 _gp. 1828-1834
856	4	0	_uhttps://doi.org/10.1093/annonc/mdt065 _zAvailable from publisher's website
999			_c22556117 _d22556117